MyFinsight
Home
Blog
About
Marketable securities
$217,628K
Cash and cash
equivalents
$84,535K
Prepaid expenses and
other current assets...
$17,359K
Accounts receivable, net
$13,013K
Operating lease
right-of-use assets
$347,661K
Total current assets
$332,535K
Property, plant and
equipment, net
$157,185K
Restricted cash and cash
equivalents, non-current
$84,565K
Intangible assets, net
$44,387K
Investments
$14,775K
Equity method
investments
$7,615K
Other non-current
assets
$1,323K
Total assets
$990,046K
Total liabilities and
stockholders equity
$990,046K
Total liabilities
$569,762K
Total stockholders
equity
$420,284K
Accumulated deficit
-$6,279,617K
Operating lease
liabilities, non-current
$404,113K
Deferred revenue, net of
current portion...
$76,537K
Total current
liabilities
$72,740K
Other non-current
liabilities
$16,372K
Additional paid-in capital
$6,698,945K
Accumulated other
comprehensive income
$950K
Common stock, 0.0001
par value (note 8)
$6K
Accrued expenses and
other current...
$49,951K
Deferred revenue
(includes 98 and 98 from...
$13,214K
Accounts payable
$9,575K
Back
Back
Balance Sheet
Ginkgo Bioworks Holdings, Inc. (DNABW)
Ginkgo Bioworks Holdings, Inc. (DNABW)
source: myfinsight.com